Auquan's Weekly Wrap | 28th - 3rd February: What you might have missed Navigating the New Normal: The Impact of Inflation, Regulations and more...
Auquan's Weekly Wrap | 21st- 27th January: What you might have missed Live Nation and Ticket Master under scrutiny by U.S. Senators, Drax Lobbying Efforts and more...
Auquan's Weekly Wrap | 14th- 20th January: What you might have missed Proposed changes to EU pharma law to tackle medicine shortages, Germany mine expansion protests and more...
Auquan's Weekly Wrap | 7th- 13th January: What you might have missed Turkish Competition Authority investigates Nestle, GlaxoSmithKline, Pepsi and more for potential violations of competition laws. More retailers exposed for forced labour in Bangladesh.
The Year Ahead: Key Themes for 2023 2022 themes to watch out for this year... China Covid Outbreak, US-China Relation Escalations, Conflicting Positions For Retailers as Cost Inflation Rises, Growing Cancer Risk Lawsuits
Auquan's Weekly Wrap | 10th- 16th December: What you might have missed Hellofresh allegations of extreme worker welfare: drug abuse, bribery, sexual harassment
Auquan launches biodiversity risk assessment tool Auquan has collaborated with Integrated Biodiversity Assessment Tool (IBAT) Alliance to launch an exhaustive biodiversity and physical risk assessment tool, following the LEAP Nature Risk Assessment Approach suggested by TNFD.
Auquan's Weekly Wrap | 26th - 2nd December: What you might have missed Invasion of privacy by RELX and Thomson Reuters. Bayer and BASP's chemical application linked to cancer risk. South Korean truckers' strike cost $1.2 bln in lost shipments.
Auquan's Weekly Wrap | 19th - 25th November: What you might have missed Deforestation impacts in the the textile industry. Mining Industry impacted from Peru & Chile Strikes. Danone, Nestlé, Marfrig, Tyson, JBS among other dairy and meat producers Contributing to over 80 per cent of the EU entire methane footprint.
Auquan's Weekly Wrap | 12th - 18th November: What you might have missed Big Alcohol draining water levels in drought ridden Mexico. Cancer Drug advancement with GSK's new facility. Carmakers subject to building lawsuits after 3G shutting down.